Overview

Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs

Status:
Completed
Trial end date:
1997-09-01
Target enrollment:
Participant gender:
Summary
The aim of this placebo controlled study is to investigate the effect of 2 mg melatonin Slow Release (Circadin®) on the sleep/wake cycle in elderly insomniac out-subjects, aged 55 years or more.
Phase:
Phase 2
Details
Lead Sponsor:
Neurim Pharmaceuticals Ltd.
Treatments:
Melatonin